Comparative Pharmacology
Head-to-head clinical analysis: CHILDREN S ADVIL versus LODINE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHILDREN S ADVIL versus LODINE.
CHILDREN'S ADVIL vs LODINE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis. This leads to decreased pain, inflammation, and fever through peripheral and central mechanisms.
Inhibition of prostaglandin synthesis via cyclooxygenase (COX) inhibition, with selectivity for COX-2 over COX-1.
Ibuprofen 200-400 mg orally every 4-6 hours as needed; maximum 1200 mg/day without prescription.
200 to 400 mg orally every 6 to 8 hours as needed; maximum daily dose 1200 mg.
None Documented
None Documented
Terminal elimination half-life is 1.9–2.3 hours in children. In neonates, half-life is prolonged (up to 6 hours). Clinical context: Requires dosing every 6–8 hours for sustained antipyresis.
Terminal elimination half-life approximately 7.5 hours; in elderly or renal impairment, half-life may be prolonged up to 10 hours, requiring dose adjustment
Renal excretion of conjugated metabolites (glucuronide and sulfate) accounts for ~90% of the administered dose. Less than 5% is excreted unchanged in urine. Biliary/fecal elimination is minor (<5%).
Primarily renal (60% as metabolites, <1% unchanged); biliary/fecal (30-35%)
Category C
Category C
NSAID
NSAID